Plus Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/07/2025 | 1.45 M | $989.63 K | 4,346.17% | 2.99% |
| ALTIUM CAPITAL MANAGEMENT LP | 11/04/2025 | 918.91 K | $628.26 K | 100.00% | 1.90% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 813.25 K | $556.02 K | 1,489.12% | 1.68% |
| UBS GROUP AG | 11/13/2025 | 623.87 K | $426.73 K | 611.88% | 1.29% |
| BLACKROCK, INC. | 11/12/2025 | 469.39 K | $320.92 K | 6,644.09% | 0.97% |
| STATE STREET CORP | 11/14/2025 | 341.89 K | $233.75 K | 100.00% | 0.71% |
| NORTHERN TRUST CORP | 11/14/2025 | 265.49 K | $181.52 K | 100.00% | 0.55% |
| SCIENTECH RESEARCH LLC | 11/14/2025 | 146.65 K | $100.27 K | 100.00% | 0.30% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 67.26 K | $45.99 K | 100.00% | 0.14% |
| MERCER GLOBAL ADVISORS INC /ADV | 11/14/2025 | 28.47 K | $19.47 K | 100.00% | 0.06% |
| DAGCO, INC. | 10/27/2025 | 25.88 K | $17.70 K | 100.00% | 0.05% |
| KESTRA ADVISORY SERVICES, LLC | 11/14/2025 | 25.80 K | $17.64 K | 100.00% | 0.05% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2025 | 11.66 K | $7.97 K | 14.05% | 0.02% |
| TWO SIGMA SECURITIES, LLC | 11/14/2025 | 11.08 K | $7.57 K | 100.00% | 0.02% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 11/12/2025 | 10.50 K | $7.00 K | 100.00% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 3.52 K | $2.41 K | -41.77% | 0.01% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 3.35 K | $2.29 K | 48.14% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 831 | $567 | 425.95% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 133 | $59 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 53 | $36 | -85.15% | 0.00% |
| BARCLAYS PLC | 11/12/2025 | 2 | $1 | 100.00% | 0.00% |
| DANSKE BANK A/S | 11/19/2025 | 1 | $1 | 100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 1 | $1 | 100.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 11/04/2025 | 0 | $0 | -100.00% | 0.00% |
| ATLANTIC UNION BANKSHARES CORP | 11/04/2025 | 0 | $0 | -100.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GROUND SWELL CAPITAL, LLC | 11/06/2025 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| TRADEWINDS CAPITAL MANAGEMENT, LLC | 10/21/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Plus Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 33 institutional investors and hedge funds held shares of Plus Therapeutics, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 1.45 M
Altium Capital Management LP: 918,914
GEODE CAPITAL MANAGEMENT, LLC: 813,250
UBS Group AG: 623,874
BlackRock, Inc.: 469,389
STATE STREET CORP: 341,893
10.78% of Plus Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 5.22 M shares in the last 24 months. This purchase volume represents approximately $3.82 M in transactions.